Shares of First Trust NYSE Arca Biotechnology Index Fund (NYSEARCA:FBT – Get Free Report ) hit a new 52-week high during trading on Thursday. The stock traded as high as $165.84 and in the most recent trade was $165.84 on volume of 2,603 shares. The stock’s previous close was $162.69.
First Trust NYSE Arca Biotechnology Index Fund shares rose 0.6%
The company’s 50-day moving average is $154.58 and its 200-day moving average is $151.98. The company has a market capitalization of $1.25 billion, a price-to-earnings ratio of 17.20 and a beta of 0.86.
Institutional investor inflows and outflows
A number of hedge funds have recently bought and sold shares of the company. WealthShield Partners LLC increased its holdings in First Trust NYSE Arca Biotechnology Index Fund by 1.8% in the second quarter. WealthShield Partners LLC now owns 3,714 shares of the company’s stock, valued at $572,000, after purchasing an additional 66 shares in the last quarter. Clear Creek Financial Management LLC increased its holdings in First Trust NYSE Arca Biotechnology Index Fund by 2.6% in the second quarter. Clear Creek Financial Management LLC now owns 4,897 shares of the company’s stock, valued at $754,000, after purchasing an additional 125 shares in the period. RPS Advisory Solutions LLC purchased a new position in First Trust NYSE Arca Biotechnology Index Fund in the second quarter, valued at approximately $1,384,000. Raymond James Financial Services Advisors increased its holdings in First Trust NYSE Arca Biotechnology Index Fund by 2.2% during the second quarter. Raymond James Financial Services Advisors now owns 121,974 shares of the company’s stock valued at $18,783,000 after purchasing an additional 2,629 shares in the last quarter. Finally, Myre Wealth LLC purchased a new position in First Trust NYSE Arca Biotechnology Index Fund worth approximately $746,000 in the second quarter.
About First Trust NYSE Arca Biotechnology Index Fund
(Get your free report)
First Trust NYSE Arca Biotechnology Index Fund (FBT) is an exchange-traded fund based on the NYSE Arca Biotechnology Index. The fund tracks an equal-weighted index of U.S. biotechnology stocks. FBT was launched on June 19, 2006 and is managed by First Trust.
read more
Get First Trust NYSE Arca Biotechnology Index Fund News and Ratings Daily – Enter your email address below to receive a concise summary of the latest news and analyst ratings on First Trust NYSE Arca Biotechnology Index Fund and related companies every day with MarketBeat.com’s free email newsletter.
